Shared insight on the evolving treatment armamentarium for metastatic CRPC and how expert physicians are optimizing care.
May 12th 2022
Experts share insight on the greatest unmet needs in treating patients with metastatic castration-resistant prostate cancer.
Before closing out their discussion, experts review novel targeted agents under investigation in metastatic CRPC.
May 19th 2022
Highlighting ongoing clinical trials in prostate cancer, experts share practical advice on optimal treatment strategies for community physicians.